What Johnson Is Selling: “Immortals” in One Sentence According to *Silicon Canals*, Johnson announced on 12 February that he’s selling access to a concierge version of his Blueprint regimen—priced at $1M/year, capped at three participants, with Johnson claiming applications are “already flooding in.”
On X, Johnson described Immortals as:
“the world’s best health program”
“the exact protocol I have followed for the last 5 years.”
The package, as described in the article, includes: - A dedicated concierge team - Continuous biological tracking across “millions of data points” - “Best skin and hair protocols” - Access to cutting-edge therapies - 24/7 access to “BryanAI”, an AI system modeled on Johnson
This isn’t positioned as a new idea so much as a premium wrapper around something he’s already made famous: turning his body into a relentlessly quantified, public-facing experiment.
Blueprint: The Public Protocol Behind the Paywall Immortals is framed as a personalized extension of Johnson’s publicly documented Blueprint, which the article characterizes as involving: - Hundreds of supplements (unspecified) - Strict dietary protocols - Rigorous exercise routines - Experimental medical interventions (unspecified)
Johnson’s credibility in tech and marketing is part of the product. He’s 48, and the article notes he made his fortune by selling Braintree to eBay for $800 million in 2013. It also reports that Johnson has said he invests more than $2 million annually into his own body—then converts the resulting biological tracking into content for millions of followers.
In other words: Immortals is not merely “health coaching.” It’s an attempt to package an entire *operating system*—tests, routines, people, tools, and decision-making—into an ultra-high-end service.
The Longevity Market Is Exploding—And Luxury Is Leading One reason Immortals doesn’t feel totally outlandish is the macro backdrop. The article cites Grand View Research estimates that the global anti-ageing industry was worth about $67 billion in 2023 and could exceed $120 billion by 2030.
It also points out that six-figure bespoke health optimization programs already exist in places like: - Switzerland - Singapore - The United States
Johnson’s move is basically “executive health clinic meets influencer-brand meets platform economics”—with a scarcity lever pulled as hard as possible.
Scarcity as a Feature: Why Only Three Spots? *Silicon Canals* interprets the three-person cap as an intentional luxury tactic—an artificial constraint designed to amplify perceived value.
That matters because it changes the conversation. At $1M/year for three people, Immortals becomes less about serving clients and more about signaling: *longevity as the ultimate status purchase*, where the buyer isn’t just purchasing interventions but proximity to a highly visible protocol and its mythology.
The Evidence Problem: Biomarkers Aren’t the Same as Outcomes The sharpest critique in the article isn’t “who would pay that?” It’s: where’s the peer-reviewed proof?
Key scientific criticisms highlighted: - Johnson has never published his anti-ageing protocol in a peer-reviewed journal (per the article). - His biological-age claims rely on epigenetic clocks and biomarker panels, whose predictive validity is actively debated. - The article notes epigenetic age tests can be influenced by short-term lifestyle changes—changes that may not translate to actual lifespan extension.
For longevity-savvy readers, this is the core tension: biomarkers are useful, but they’re not endpoints. A number can shift without proving you’ve changed the underlying trajectory of aging in a way that will cash out as more years—or better years.
“Cutting-Edge” vs. Credible: The Self-Experimentation Track Record The article also spotlights Johnson’s more controversial experiments, including: - Blood plasma transfusions from his teenage son, which he later abandoned - Public experimentation with psilocybin
These are exactly the kinds of interventions that create two simultaneous effects: intense attention in biohacking circles and skepticism from mainstream medicine. They also underscore an uncomfortable truth: high-budget experimentation can blur into high-budget spectacle.
BryanAI: The Real Product Might Be a Scalable “Longevity Platform” Immortals includes 24/7 access to BryanAI, but the article says Johnson has not disclosed its technical architecture. The implication, according to *Silicon Canals*, is that it draws on his accumulated biological data and protocol knowledge to generate personalized guidance.
This is where the story stops being only about concierge medicine and starts being about platform-building. The article suggests AI could allow Johnson to scale his personal brand beyond a handful of ultra-wealthy clients—potentially to lower price points—turning him into what it calls a “longevity platform.”
But the article also flags the obvious landmines: - Liability: who is responsible if someone is harmed? - Medical regulation: is this “coaching,” or does it become medical advice when it’s based on personalized biological data? - Accountability: the article notes Johnson and his team haven’t publicly addressed responsibility if clients are harmed
In longevity, “personalization” is the magic word—and also the word that drifts closest to regulated medical practice.
Inequality: Longevity as a Class Advantage (Supercharged) The piece places Immortals inside a broader social reality: in OECD countries, wealthier individuals already live significantly longer on average than lower-income counterparts, attributed in the article to factors like better nutrition, preventive care, lower stress, and cleaner environments.
It argues programs like Immortals could accelerate a two-tier system—*if even a fraction of these interventions prove effective*—where the ability to slow biological aging is increasingly tied to socioeconomic status.
The Most Underrated Takeaway: The “Boring Basics” Still Dominate The article cites Peter Attia’s view that the most impactful longevity interventions are largely accessible and inexpensive, including: - Exercise - Sleep optimization - Metabolic health management
And he warns that flashy high-cost programs can distort public understanding and divert attention and resources from foundational public health.
That’s the paradox Immortals creates: it’s marketed as the pinnacle of optimization, yet it may inadvertently reinforce the idea that longevity is bought through exclusivity rather than earned through consistent, unsexy fundamentals.
Practical Takeaways: How to Think Like a Longevity Investor (Without Paying $1M) Immortals is a headline, but the meta-lessons are actionable:
- Treat biological age tests as *signals*, not verdicts. The article emphasizes they’re debated and can be moved by short-term changes.
- Be wary of “protocol worship.” The article’s central criticism is that the regimen isn’t peer-reviewed—so separate what’s measurable from what’s proven.
- Don’t outsource the basics. Even critics cited in the piece emphasize that exercise, sleep, and metabolic health are still the highest-ROI levers.
- Watch the AI layer. If BryanAI (or similar systems) becomes common, the biggest question won’t be novelty—it will be regulatory clarity and accountability.
Source: [Bryan Johnson wants $1M per year to share his longevity secrets. The criticism is already pouring in](https://siliconcanals.com/j-a-tns-bryan-johnson-wants-1m-per-year-to-share-his-longevity-secrets-the-criticism-is-already-pouring-in/) — *Silicon Canals*, 12 February